Skip to main content
OpenTrials
Completed

NCT Number: NCT05522088

Effectiveness of Prophylactic Bolus Ephedrine Versus Norepinephrine for Management of Post Spinal Hypotension

This study was conducted to compare the effectiveness of ephedrine versus norepinephrine for management of hypotension after spinal anesthesia for mothers undergoing elective cesarean section

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

Wachemo University

Hosa’ina, Ethiopia

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA class II and ages ranging from 18-35 years were included in the study

Exclusion criteria

  • pregnant women with preeclampsia/eclampsia, baseline hypertension (SBP> 140 mm Hg), BMI> 30 kg/m2, failed spinal, spinal anaesthesia converted to general anaesthesia, contraindication for spinal anaesthesia and mother with cardiovascular, renal or hepatic disease.

Treatment and study plan

Primary outcomes

  1. to compare mean blood pressure (MAP) between the groups

    Time frame: From March,01 to April, 30/2022

Sponsors and collaborators

Lead sponsor

Wachemo University

Other

Registry information

Official study title

Effectiveness of Prophylactic Bolus Ephedrine Versus Norepinephrine for Management of Post Spinal Hypotension During Elective Caesarean Section in Resource Limited Setting: a Prospective Cohort Study

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Aug 30, 2022
Registry last updated
Aug 30, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.